Although extensive research is being
done to combat SARS-CoV-2,
we are yet far away from a robust conclusion or strategy. With an
increased amount of vaccine research, nanotechnology has found its
way into vaccine technology. Researchers have explored the use of
various nanostructures for delivering the vaccines for enhanced efficacy.
Apart from acting as delivery platforms, multiple studies have shown
the application of inorganic nanoparticles in suppressing the growth
as well as transmission of the virus. The present review gives a detailed
description of various inorganic nanomaterials which are being explored
for combating SARS-CoV-2 along with their role in suppressing the
transmission of the virus either through air or by contact with inanimate
surfaces. The review further discusses the use of nanoparticles for
development of an antiviral coating that may decrease adhesion of
SARS-CoV-2. A separate section has been included describing the role
of nanostructures in biosensing and diagnosis of SARS-CoV-2. The role
of nanotechnology in providing an alternative therapeutic platform
along with the role of radionuclides in SARS-CoV-2 has been described
briefly. Based on ongoing research and commercialization of this nanoplatform
for a viral disease, the nanomaterials show the potential in therapy,
biosensing, and diagnosis of SARS-CoV-2.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.